MedTrace Logo

Assessing the Wear Rates of the ADM/MDM Hips Using 3D X-ray Analysis

NCT04019925 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2019-07-15

No results posted yet for this study

Summary

A common complication post hip replacement is hip dislocation or hip instability which can lead to the hip implants being revised. A new generation of Dual Mobility hips was designed to minimize hip dislocation/hip instability and polyethylene wear thus increasing the longevity of the hip prosthesis and reducing the number of re-operations for a patient. In this study we will be assessing 2 dual mobility hips manufactured by Stryker Orthopaedics Inc. The ADM and the MDM.

Conditions

  • Arthroplasty, Replacement, Hip

Interventions

DEVICE

ADM/MDM hip

Dual Mobility Hip prosthesis manufactured by Stryker Orthopaedics: ADM/MDM

Sponsors & Collaborators

  • Stryker Orthopaedics

    collaborator INDUSTRY

  • Unity Health Toronto

    lead OTHER

Principal Investigators

  • Amit Atrey, MD · Unity Health Toronto, St. Michael's Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-09-01
Primary Completion
2020-03-30
Completion
2020-08-31
FDA Device
Yes

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04019925 on ClinicalTrials.gov